🚚 FREE U.S. Shipping on Orders Over $500
SKU: TESAMORELIN-10mg

TESAMORELIN (10mg)

Tesamorelin is a synthetic 44-residue peptide analog of growth hormone-releasing hormone (GHRH), produced through controlled peptide synthesis and stabilized by a trans-3-hexenoic acid modification at the N-terminus. It shares the core 44-amino-acid sequence of the endogenous releasing factor, and the N-terminal lipid modification is associated with extended serum persistence relative to native GHRH, which is a relevant characteristic for its use as a stable reference compound in laboratory settings.

In research applications, Tesamorelin is studied for its interaction with pituitary GHRH receptors and the downstream growth hormone / IGF-1 signaling cascade. It falls within the GHRH-analog category of secretagogue research compounds studied in this area.

Each batch is synthesized in a USA-registered GMP facility and characterized by HPLC and LC-MS.

All material is supplied strictly for laboratory research use.

Structural Information

Property Value
CAS Number 901758-09-6 (acetate)
PubChem CID 44147413
Molecular Formula C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular Weight 5196 g/mol
UNII LGW5H38VE3

$99.00

Choose Quantity

Description

Tesamorelin is a synthetic 44-residue peptide analog of growth hormone-releasing hormone (GHRH), produced through controlled peptide synthesis and stabilized by a trans-3-hexenoic acid modification at the N-terminus. It shares the core 44-amino-acid sequence of the endogenous releasing factor, and the N-terminal lipid modification is associated with extended serum persistence relative to native GHRH, which is a relevant characteristic for its use as a stable reference compound in laboratory settings.

In research applications, Tesamorelin is studied for its interaction with pituitary GHRH receptors and the downstream growth hormone / IGF-1 signaling cascade. It falls within the GHRH-analog category of secretagogue research compounds studied in this area.

Each batch is synthesized in a USA-registered GMP facility and characterized by HPLC and LC-MS.

All material is supplied strictly for laboratory research use.

Structural Information

Property Value
CAS Number 901758-09-6 (acetate)
PubChem CID 44147413
Molecular Formula C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular Weight 5196 g/mol
UNII LGW5H38VE3

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Scientific Reviewer

Scientifically reviewed by Dr. Julian H. Park, MD. Dr. Park serves as Scientific Reviewer for Universal BioLabs, helping uphold the accuracy, credibility, and scientific rigor of all technical content and research citations. He earned his medical degree from the University of California, Irvine School of Medicine and completed residency training in family medicine at Cedars-Sinai Medical Center. With more than 20 years of clinical experience, Dr. Park reviews research citations, study interpretations, and technical content for scientific accuracy.

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. They are not medical advice, legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, appropriate consultation with qualified research professionals, medical experts, or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0